Very‐high frequency plasmapheresis and donor health–absence of evidence is not equal to evidence of absence
Year: 2023
Type: article
Abstract: H.V.R., and V.C are employed by Belgian Red Cross–Flanders, responsible and reimbursed for supplying adequate quantities of safe blood products to hospitals in Flanders and Brussels. P.T. is employed by the Etablissement Français du Sang, the French transfusion public service in charge of blood, plasma, and platelet collection in France. K.V.D.H. is employed by Sanquin, responsible for safe blood supply in the Netherlands. C.E. is employed by the Department of Clinical Immunology, Aarhus University Hospital responsible for blood, plasma, and platelet collection in the Central Denmark Region. C.E. has received unrestricted research grants from Novo Nordisk and Abbott Diagnostics administered by Aarhus University and Aarhus University Hospital, respectively. C.E. has not received personal fees.
Source: Transfusion
DOI: 10.1111/trf.17601
Authors: Hans Van Remoortel, Katja van den Hurk, Veerle Compernolle, Peter O'Leary, Pierre Tiberghien, Christian Erikstrup
Institutions: Rode Kruis-Vlaanderen, KU Leuven, Sanquin, Amsterdam Public Health, Amsterdam University Medical Centers, Ghent University, European Blood Alliance, Inserm, Établissement Français du Sang, Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique, Université de Franche-Comté, Aarhus University, Aarhus University Hospital
Language: English
Subfield: Management of Technology and Innovation
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W4388831385